[ad_1] The maker of Lysol, Clearasil and Enfamil baby formula posted solid results that should reassure investors it is on track. [ad_2] Source link
Tag: Nondurable Household Products
First Test for Amgen: Fix Horizon’s Growth Problem
[ad_1] Markets Heard on the Street Sales of Horizon’s thyroid-eye disease drug Tepezza have plateaued, a challenge its new owner will need to contend with [ad_2] Source link
Consumer Staples Wipeout Continues With Kimberly-Clark
[ad_1] The company continued a soft streak for makers of everyday household goods, putting up weak guidance for 2023 that disappointed investors. [ad_2] Source link